Showing results (451-460 of 620) with videos related to
Sort By:
Pageof 62
Journal of Oral Rehabilitation|March 29, 2014
Management of shortened dental arches and periodontal health: 5-year results of a randomised trialM H Walter, B Marré, K Vach, et al.Neuro-Oncology Advances|June 18, 2026
Sonobiopsy for enrichment of circulating microRNAs in glioma patientsJinyun Yuan, Yuanxiang Li, Chih-Yen Chien, et al.Medrxiv : the Preprint Server for Health Sciences|March 30, 2023
First-in-human prospective trial of sonobiopsy in glioblastoma patients using neuronavigation-guided focused ultrasoundJinyun Yuan, Lu Xu, Chih-Yen Chien, et al.NPJ Precision Oncology|September 16, 2023
First-in-human prospective trial of sonobiopsy in high-grade glioma patients using neuronavigation-guided focused ultrasoundJinyun Yuan, Lu Xu, Chih-Yen Chien, et al.Vaccine|January 23, 2024
Background incidence rates of health outcomes in populations at risk for Lyme disease using US administrative claims dataJill Dreyfus, Swapna Munnangi, Camilla Bengtsson, et al.Vaccine|February 3, 2024
Obstetric and neonatal outcomes in South AfricaClare L Cutland, Shobna Sawry, Lee Fairlie, et al.Journal of Oral Rehabilitation|October 6, 2005
Effects of prosthetic treatment for shortened dental arches on oral health-related quality of life, self-reports of pain and jaw disability: results from the pilot-phase of a randomized multicentre trialS Wolfart, G Heydecke, R G Luthardt, et al.Vector Borne and Zoonotic Diseases (Larchmont, N.Y.)|April 18, 2023
Incidence of Lyme Borreliosis in the Dutch General Practice Population: A Large-Scale Population-Based Cohort Study Across the Netherlands Between 2015 and 2019Eline Houben, Hilda de Jong, Fernie Penning-van Beest, et al.British Journal of Pharmacology|September 30, 2011
Molecular pharmacological profile of a novel thiazolinone-based direct and selective 5-lipoxygenase inhibitorB Hofmann, C B Rödl, A S Kahnt, et al.Parkinsonism & Related Disorders|May 12, 2005
Pathogenesis of levodopa-induced dyskinesia: focus on D1 and D3 dopamine receptorsC Guigoni, I Aubert, Q Li, et al.Pageof 62